Overview

Study of Bemnifosbuvir on Cardiac Repolarization in Healthy Subjects

Status:
Completed
Trial end date:
2023-05-31
Target enrollment:
Participant gender:
Summary
This study will assess the effects of Bemnifosbuvir on cardiac repolarization in healthy Adult Subjects
Phase:
Phase 1
Details
Lead Sponsor:
Atea Pharmaceuticals, Inc.
Treatments:
Moxifloxacin